Thinking of joining a study?

Register your interest

NCT04606732 | RECRUITING | Covid19


CardioVascular Disease Progression and Prognosis in COVID-19
Sponsor:

University of Bologna

Information provided by (Responsible Party):

Olivia Manfrini, MD

Brief Summary:

The CVP-COVID19 registry is both a retrospective and prospective study design in order to identify predictors of cardiovascular disease progression and mortality for COVID-19. The registry enrolls consecutive patients with positive microbiological tests for SARS-CoV-2 admitted to an academic hospital in northern Italy for worsening of COVID-19 symptoms. The study does not test any new diagnostic or therapeutic approach. Patients are treated according to good clinical practice. Patients characteristics, including medical history (with particular attention to cardiovascular and pneumological risk factors), features of physical examination, results laboratory and radiological tests and treatments (pre- and in-hospital) are related with patient outcome. Logistic analysis (univariate, multivariate and propensity) are performed in order to identify factors associated with disease progression. Primary endpoint: mortality.

Condition or disease

Covid19

Detailed Description:

Members of the Steering Committee: Olivia Manfrini (Università di Bologna, Italy) Raffaele Bugiardini (Università di Bologna, Italy) Stefano Nava (Università di Bologna, Italy) Elisabetta Poluzzi (Università di Bologna, Italy) Maria Carla Re (Università di Bologna, Italy) Caterina Vocale (Policlinico Sant'Orsola) Study Coordinator: Edina Cenko (Università di Bologna, Italy)

Study Type : OBSERVATIONAL
Estimated Enrollment : 2000 participants
Official Title : Cardiovascular Clinical Features and Cardiovascular Therapies in the Development, Progression and Outcome of Patients with SARS-Cov-2 Related Pneumonia
Actual Study Start Date : 2020-09-20
Estimated Primary Completion Date : 2025-12-31
Estimated Study Completion Date : 2025-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • hospitalization for COVID-19
Exclusion Criteria
  • age \<18 years

CardioVascular Disease Progression and Prognosis in COVID-19

Location Details

NCT04606732


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Italy,

Sant'Orsola Polyclinic

Bologna, Italy, 40138

Loading...